MEDICALE CORP (MCLE) Financials
Newest figures come from the 10-Q for Q1 FY2026, filed Feb 17, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MCLE SEC filings page.
This page shows MEDICALE CORP (MCLE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
MEDICALE CORP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
MEDICALE CORP reported a net loss of $41K while operations used $23K of cash. With neither figure positive, the ratio between the two carries no quality signal.
MEDICALE CORP reported an operating loss of $33K against $8K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
MEDICALE CORP reported -$5K in net income in Q1 2026.
Not reported for Q1 2026.
Not reported for Q1 2026.
Cash & Balance Sheet
MEDICALE CORP held $0 in cash as of Q1 2026; long-term debt is not reported for that period.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
None of these metrics is reported for Q1 2026.
Capital Allocation
None of these metrics is reported for Q1 2026.
MCLE Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| SG&A Expenses | $3K | N/A | $4K | $6K | N/A | N/A | N/A | N/A |
| Operating Income | -$3K | N/A | -$4K | -$6K | N/A | N/A | N/A | N/A |
| Interest Expense | $2K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $0 | N/A | $0 | $0 | $0 | N/A | $0 | $0 |
| Net Income | -$5K | N/A | -$6K | -$8K | N/A | N/A | N/A | N/A |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted Shares (Avg) | 6M0.0% | N/A | 6M0.0% | 6M0.0% | 6M0.0% | N/A | 6M0.0% | 6M0.0% |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA.
MCLE Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $1590.0% | $1590.0% | $1590.0% | $1590.0% |
| Current Assets | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $1590.0% | $1590.0% | $1590.0% | $1590.0% |
| Cash & Equivalents | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $1590.0% | $1590.0% | $1590.0% | $1590.0% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $145K+25.6% | $140K+41.4% | $129K+57.4% | $124K+72.7% | $116K+92.4% | $99K+142.4% | $82K+208.5% | $72K+296.1% |
| Current Liabilities | $32K+45.1% | $34K+117.0% | $29K+108.3% | $26K+100.1% | $22K+84.9% | $16K-62.1% | $14K-47.0% | $13K-28.4% |
| Non-Current Liabilities | $113K+20.9% | $106K+27.3% | $100K+46.9% | $98K+66.6% | $94K+94.2% | $84K | $68K | $59K |
| Total Equity | -$145K-25.7% | -$140K-41.6% | -$129K-57.7% | -$124K-73.0% | -$116K-92.6% | -$99K-143.0% | -$82K-209.7% | -$72K-298.7% |
| Retained Earnings | -$222K-15.5% | -$217K-23.4% | -$206K-29.8% | -$201K-35.2% | -$193K-40.6% | -$176K-49.5% | -$159K-53.7% | -$149K-56.5% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
MCLE Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
MCLE Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$140K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where MEDICALE CORP Ranks
Frequently Asked Questions
Is MEDICALE CORP profitable?
No, MEDICALE CORP (MCLE) reported a net income of -$41K in fiscal year 2025.
What is MEDICALE CORP's operating cash flow?
MEDICALE CORP (MCLE) recorded an outflow of $23K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are MEDICALE CORP's total assets?
MEDICALE CORP (MCLE) had $0 in total assets as of fiscal year 2025, including both current and long-term assets.
What is MEDICALE CORP's current ratio?
MEDICALE CORP (MCLE) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
How does MEDICALE CORP's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, MEDICALE CORP (MCLE) held $0 in cash, cash equivalents and investments, and reported an operating cash outflow of $23K over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is MEDICALE CORP's debt-to-equity ratio negative or not reported?
MEDICALE CORP (MCLE) has negative shareholder equity of -$140K as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Are MEDICALE CORP's earnings high quality?
MEDICALE CORP (MCLE) reported a net loss of $41K while operations used $23K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can MEDICALE CORP cover its interest payments?
MEDICALE CORP (MCLE) reported an operating loss of $33K against $8K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.